KSQ-4279, a first-in-class USP1 inhibitor shows strong combination activity with multiple PARP inhibitors in BRCA mutant cancers-MedSci.cn

KSQ-4279, a first-in-class USP1 inhibitor shows strong combination activity with multiple PARP inhibitors in BRCA mutant cancers

Tobin, E; Sullivan, P; Murray, M; Gannon, H; Dodson, A; Shenker, S; Stegmeier, F; Wylie, A; Cadzow, L

CANCER RESEARCH, 2023; 83 (7):

科室
- - 订阅+
  - 更多科室
工具
服务